Artal International Management S.A., Director, 10% Owner at LEXICON PHARMACEUTICALS, INC. (LXRX), bought 651,278 shares at $12.45 ($8.2M) on 2018-06-05, disclosed to the SEC on 2018-06-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.45 | 173,121 | $2.2M | 26.3% |
| 2 | $12.45 | 173,121 | $2.2M | 26.3% |
| 3 | $12.58 | 95,079 | $1.2M | 14.6% |
| 4 | $12.58 | 95,079 | $1.2M | 14.6% |
| 5 | $12.93 | 57,439 | $743K | 9.1% |
| 6 | $12.93 | 57,439 |
| $743K |
| 9.1% |
| Total | $12.57 avg | 651,278 | $8.2M | 100% |
| Filing → |
| LXRX | BUY | 2018-06-18 | $1.1M | — | Filing → |
| LXRX | BUY | 2018-05-30 | $7.3M | — | Filing → |
| WTW | BUY | 2014-08-14 | $2.9M | — | Filing → |